Alzheimer's disease (AD) is the most common cause of dementia and identifying early markers of this disease is important for prevention and treatment strategies. Amyloid -ߚ protein deposition is one of the earliest detectable pathological changes in AD. But in-vivo detection of amyloidour results show feasibility of amyloidβ prediction by MRI.
ߚ using positron emission tomography (PET) is hampered by high cost and limited geographical accessibility. These factors can become limiting when PET is used to screen large numbers of subjects into prevention trials when only a minority are expected to be amyloidβ positive. Structural MRI is advantageous; as it is relatively inexpensive and more accessible.
Thus it could be widely used in large studies, even when frequent or repetitive imaging is necessary. We used a machine learning, pattern recognition, approach using intensity-based features from individual and combination of MR modalities (T1 weighted, T2 weighted, T2 fluid attenuated inversion recovery [FLAIR] , susceptibility weighted imaging) to predict voxel-level amyloidβ in the brain. The MRa m y l o i d ߚ relation was learned within each subject and generalized across subjects using subject-specific features (demographic, clinical, and summary MR features) . When compared to other modalities, combination of T1-weighted, T2-weighted FLAIR, and SWI performed best in predicting the amyloidβ status as positive or negative. T2weighted performed the best in predicting change in amyloidβ over two timepoints. Overall,
Introduction
Alzheimer's disease (AD) is a neurodegenerative disease affecting more than 5 million people in the US. It has been identified as the most common cause of dementia in people 60 years and older (Alzheimer's, 2019) . The disease is believed to begin with pathological changes, including accumulation of amyloidβ protein; followed by tau protein tangles, hypometabolism, inflammation and brain atrophy several years before the cognitive and clinical symptoms are apparent (Jack et al., 2010; Sperling et al., 2011) . As one of the earliest detectable pathological changes in AD, amyloidβ deposition is a primary target for prevention and treatment strategies (Weninger et al., 2016) . In-vivo measurement of amyloidβ plaques is performed using positron emission tomography (PET) (Villemagne, 2016) . There is evidence that biormarkers identifiable by PET (Amyloidβ and hypo-metabolism) appear during the preclinical stages of AD (Cohen and Klunk, 2014; Jack et al., 2012; Marcus et al., 2014; Sperling et al., 2011) and can predict decline years before the onset of symptoms (Cohen and Klunk, 2014) . In-vivo amyloidβ imaging is essential in definitive diagnosis of AD and important for the early detection of AD (Adlard et al., 2014) . However limited access and high cost restrict the use of amyloidβ PET `scans.
Structural MRI is widely accessible and is relatively inexpensive. If MRI predictors of amyloidβ deposition could be defined, MRI could have advantages over PET in several areas:
as a screening tool in large prevention studies where large numbers of potential subjects need to be screened, where frequent or repetitive imaging is necessary, and perhaps for monitoring disease progression and evaluation of treatment.
Greater levels of amyloidβ plaque in the brain are associated with worsened structural brain integrity. Amyloid-β deposition is associated with reduced cortical thickness in parietal, posterior cingulate and precuneus regions (Becker, 2011 ) (Dore, 2013 and hippocampus (Dore, 2013) more specifically entorhinal cortex (Doherty, 2015) . Regional changes in brain structure quantified using changes in MR intensities can help predict regional amyloidβ deposition. The subtle changes in the local pattern of image intensity (textures) across voxels can be detected using image texture analysis (Maani et al., 2015) .
MRI texture analysis studies have shown promise in characterizing brain tumors (Zacharaki et al., 2009) In this study, we use intensity based voxel-level imaging features extracted from both individual modalities and a combination of modalities to predict voxel-level amyloidβ . We use regression models to perform amyloidβ status prediction across subjects (least absolute shrinkage and selection operator (LASSO) and partial least squares (PLS)) and amyloidβ change prediction within subjects (LASSO). Imaging data from fourteen subjects are used in the within subject prediction and thirty-five subjects are used for the prediction across subjects. The machine learning algorithm takes advantage of the voxel-wise data. Thus, the effective sample size for machine learning is > 10,000 examples. The MRI based approach proposed here could offer promise for characterizing voxel-level amyloidβ burden on cross-sectional data and also potentially tracking amyloidβ burden longitudinally.
Materials and Methods

Parent Study and Subjects
This study was part of an ongoing longitudinal study (started in 2007) (RF1 AG025516) at the University of Pittsburgh . In 2011, the MR scanning for this study switched to a Siemens 3T TRIO MR scanner. For the current study we selected all subjects who underwent at least one scan on the 3T TRIO scanner between 2011 and 2017). If they had more than one session on the 3T scanner then we chose the 1 st scan that had all MR sequences (T1-weighted, T2-weighted, SWI, T2 FLAIR 
PET scanning: Pittsburgh Compound-B (PiB)
[11C]PiB was produced as previously described (Price 2005). PET imaging was conducted using a Siemens/CTI ECAT HR + (3D mode, 15.2 cm field-of-view, 63 planes, reconstructed image resolution ~ 6 mm FWHM). The participant's head was immobilized to minimize head motion.
PiB was injected intravenously (12-15 mCi, over 20 s, specific activity ~ 1-2 Ci/μmol) and PET scanning was performed over an interval that included 50-70 min post injection. Images were quantified using standard uptake value ratio (ratio of tissue radioactivity to the reference region(cerebellum)).
MRI Preprocessing
All data were preprocessed using statistical parametric mapping software (SPM12). All structural scans (T2-weighted, FLAIR SWI) were linearly registered (normalized mutual information similarity metric and 4 th degree B-spline interpolation) to the MPRAGE. These images were then segmented (using the multi-spectral segmentation that utilizes each channel to improve segmentation) into gray matter (GM), white matter (WM), cerebrospinal fluid (CSF), skull, softtissue, and air (outputs a probability map for each class). The GM, WM, and CSF were threshold at a probability of 0.1, and added to create an initial intracranial volume mask, which was then refined using an image filling algorithm as well as an image-closing (disk structuring element of 1 voxel) algorithm in MATLAB. The MPRAGE was then linearly registered (normalized mutual information similarity metric with 4 th degree B-spline interpolation) to the PET image and that transformation was applied to all other structural scans as well as the GM, WM, and CSF segmentations.
For the longitudinal data an additional within subject registration was performed. The MRI data from two timepoints were registered to the PET data of the baseline. In addition to that the PET data were also registered to the baseline timepoint PET data.
PET Processing
PET data were corrected for photon attenuation, scatter, scanner deadtime, accidental coincidences, and radioactive decay. The final reconstructed PET image resolution was ~6 mm (transverse and axial) based on in-house point source measurements. If subject motion was present then the data were also corrected for inter-frame motion by applying a more extensive registration procedure prior to the PET to MR alignment. The ROI sampling is performed using 
Overview of Prediction Algorithm
Our overall approach is designed to take advantage of the high dimensionality of the withinsubject imaging data to predict the MR-amyloidβ relationship. The MR-amyloidβ relationship developed within subject is used for prediction on longitudinal change in amyloidβ . We then generalize the MR-amyloidβ relationship across subjects, using the subject-level features, to dichotomize amyloidβ status.
Determining voxel -level association between MR and Aβ
Feature Extraction
Features were obtained from the native resolution of MR modalities before registration to PET data (i.e., T1, T2, T2 FLAIR and SWI). The specific imaging features used are intensity, 3D gradient, Gabor filter, local binary pattern (intensity-based neighborhood encoding method with detailed description in supplement). Texture can be described as fine or coarse, regular or irregular, and homogeneous or heterogeneous. Gabor filters help characterize homogeneity of texture in the spatial frequency domain. Local binary patterns are a unique way of encoding neighborhood intensity information. 3D gradients highlight regions with rapid change in intensities across voxels. MR signal intensities and Gabor filtered images were obtained from all modalities. 3D gradient features and local binary patterns (LBP) and are usually summarized as histograms. For highlighting voxel-level changes, these features will be most useful in T1weighted imaging due to its high-resolution with clear contrast in intensities between gray matter and white matter. Hence the voxel-level LBP and 3D gradients are obtained only from T1weighted imaging. Feature images were then registered to PET (PiB). A combined gray matter and white matter mask (GM+WM) was applied to each of these feature images for obtaining the
. The distributions of the features were skewed hence a performed.
LASSO Model
LASSO is a regularized regression that penalizes the number of non-zero parameter estimates and allows for selection of features that are most predictive of the outcome (Tibshirani, 1996) .
Features were extracted from voxels within combined gray matter (GM) and white matter (WM) mask (for training LASSO) and 6 volumes of interest (for prediction). For training, voxels from GM+WM mask (~20,000 for each subject) were used to allow space for greater variance in MR features and amyloidβ to improve the learning of the voxel-level MR-amyloidβ relationship.
The prediction was performed on voxels within 6 VOIs. The general equation for LASSO regression has a least square minimization term and a penalization term, where ߣ is a regularization parameter, ‫ݒ‬ is the total number of voxels,
. The regularization parameter ߣ was estimated via cross-validation using 5% of the voxels. All the voxels within each subject were then used to predict the LASSO parameters
These LASSO model parameters can be applied to MR imaging of the same subject at a future time point for predicting amyloidβ change (2.6.1.1). The LASSO models can be generalized across subjects for predicting amyloidβ status (2.6.1.2).
Evaluation Metrics
The prediction performance was evaluated using accuracy (no of. correct label classifications / total number of cases), F-score defined using Precision (positive prediction rate)
, area under the receiver operating characteristic (ROC) curve (AUC), and spearman rank correlation coefficient. Final individual/combination of modalities are ranked using each of these evaluation metrics and average ranking is used to obtain the most predictive modalities (least rank value).
Amyloidβ status prediction across subjects
Subject-level features include demographics (age, weight, sex, race), white matter hyper intensitity burden (WMH), hippocampal volume, and normalized gray and white matter volumes.
Partial least squares (PLS) regression was used to learn the relationship between subject-level features and LASSO parameters. Since there are a greater number of amyloidβ negative subjects, we followed the cross-validation scheme established in previous literature (Mathotaarachchi et al., 2017) for rebalancing the data set. We split the data (N=35) into subsets with equal representation of positives and negatives. For each subset, all PiB+ (9) subjects were combined with random combinations of PiB-(9) subjects.
For each subset, a nested leave-one-out-cross-validation ( 
Results
Amyloidβ status prediction across subjects
The features from multimodal magnetic resonance imaging were able to predict regional amyloidβ . The regional amyloidβ obtained voxel level is then used to calculate the global PiB and that metric is used for classification. The combination of T1-weighted, T2-weighted FLAIR, and SWI modalities performed the best for amyloidβ status classification [Average over 20 subsets: F-score (Mean (SD)): 68.2515 (7.5785), Accuracy (Mean (SD)): 66.3889 (8.156), AUC 0.6639 (0.0816); Spearman correlation coefficient (Mean (SD)): 0.4062 (0.1304)]
( Table 1. ). Figure 2 shows the mean original and the predicted amyloidβ for one subset (18 subjects) with 3 false positives (FP), 1 false negatives (FN), 8 true positives (TP), and 5 true negatives (TN), thus showing a high sensitivity and medium specificity performance. The false positive predictions could also be an identification of risk subjects. When we examined the 3 false positive subjects we noticed that 2 of them demonstrated regional amyloidβ positivity (one or more of the 6 regions showed high amyloidβ deposition). The one false negative had an original threshold as 1.53 slightly above the threshold (of 1.51) which could be possible that the subject is misclassified. The threshold is predicted for each left-out subject using the nested LOOCV. We found that summary MR measures, demographics, and the combination all performed worse (with decision tree learning) than the voxel-level amyloidβ prediction results described above. The F-scores were less than the predicted amyloid- 
Amyloidβ change prediction within subject
For predicting the increase in amyloidβ across two timepoints, T2-weighted imaging alone had the the best performance [For N=13 subjects: F-score: 83.33, accuracy = 84.62; AUC = 0.85
Spearman correlation coefficient = 0.81] (Table 2. ).
Discussion
The different MR imaging modalities carry complementary information about regional structural integrity. Several imaging features, from each of these modalities, were combined in a two-level approach (voxel-level and subject-level) to estimate amyloidβ status across subjects and estimate within-subject change in amyloidβ . Results of our analyses demonstrate that estimation of amyloidβ deposition could be successfully achieved using individual or a combination of MR modalities. In this approach, subject-level learning involved generalizing the LASSO parameters across subjects, hence inter-subject registration using template normalization -which can introduce variability -was not required. The approach predicts voxel-level amyloidβ , which can aid in both qualitative and quantitative analysis of regional amyloidβ burden.
For across subject amyloidβ status prediction, the combination of T1-weighted, T2weighted FLAIR and SWI modalities were most predictive. This could be because the summary subject-features were most correlated with these modalities. The subject-level MR features like WMH and hippocampal volume are obtained from T1-weighted and T2-weighted FLAIR. The FP could be indicative of increasing regional amyloidβ burden although this finding still needs full validation. The PiB status prediction was better using both voxel-wise MR and summary subject-level features than using only summary subject-level measures. This suggests that there is information in MR signal at the voxel-level that is associated with amyloid- , 2018) . They used subject demographics, cognitive variables, regional estimates of volume and cortical thickness from MRI, and APOE ε 4 information along with machine learning classifier called support vector machine (SVM) with nested 10-fold crossvalidation to identify the best discriminating features between amyloidβ positive and amyloid-β negative groups. In our study however, we did not use any cognitive measures since we focused on preclinical biomarkers in cognitively normal older adults. To our knowledge, this is the first study that explores the use of voxel-level MR features to predict global amyloidβ deposition in cognitively normal subjects.
One limitation is our relatively small sample size. Although our current results suggest the voxel-level MR features can predict global amyloidβ status, we suspect with more modalities, more features, including asymmetry filters, and a larger set of images the learning would be much better. Deep learning approaches, such as convolution neural networks on large data sets is a promising future direction. This result demonstrates how voxel-level imaging data can be leveraged for prediction across individuals, and across time.
Conclusions
In conclusion, this paper describes an approach for using image processing and pattern recognition techniques to predict amyloidβ deposition.
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